Tzu‐Wen Lien

1.0k total citations
17 papers, 644 citations indexed

About

Tzu‐Wen Lien is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tzu‐Wen Lien has authored 17 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tzu‐Wen Lien's work include Peroxisome Proliferator-Activated Receptors (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Tzu‐Wen Lien is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Tzu‐Wen Lien collaborates with scholars based in Taiwan and India. Tzu‐Wen Lien's co-authors include Hsing‐Pang Hsieh, Chih‐Cheng Huang, Yen-Ling Song, Chun I. Yu, Su‐Ying Wu, John Hsu, Wen‐Hsing Lin, John T.-A. Hsu, Xin Chen and Yu‐Sheng Chao and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Tzu‐Wen Lien

17 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tzu‐Wen Lien Taiwan 12 341 127 114 101 72 17 644
Bruce Wisely United States 10 532 1.6× 97 0.8× 339 3.0× 119 1.2× 87 1.2× 11 1.2k
Alex Philchenkov Ukraine 14 451 1.3× 61 0.5× 123 1.1× 175 1.7× 8 0.1× 39 812
Xia‐Juan Huan China 18 325 1.0× 37 0.3× 137 1.2× 114 1.1× 14 0.2× 41 674
Yongchun Shen United States 19 498 1.5× 96 0.8× 77 0.7× 313 3.1× 26 0.4× 47 1.0k
Jessica E. Friedman United States 6 331 1.0× 112 0.9× 87 0.8× 101 1.0× 78 1.1× 7 625
Shingo Yogosawa Japan 19 629 1.8× 33 0.3× 180 1.6× 74 0.7× 14 0.2× 29 969
Ying Hou China 17 441 1.3× 71 0.6× 77 0.7× 63 0.6× 16 0.2× 30 735
Joan Villena Chile 16 384 1.1× 37 0.3× 49 0.4× 116 1.1× 9 0.1× 64 805
Meiyang Xi China 15 534 1.6× 68 0.5× 113 1.0× 189 1.9× 47 0.7× 29 745
Taichi Ohshiro Japan 20 548 1.6× 108 0.9× 60 0.5× 138 1.4× 38 0.5× 72 1.1k

Countries citing papers authored by Tzu‐Wen Lien

Since Specialization
Citations

This map shows the geographic impact of Tzu‐Wen Lien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tzu‐Wen Lien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tzu‐Wen Lien more than expected).

Fields of papers citing papers by Tzu‐Wen Lien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tzu‐Wen Lien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tzu‐Wen Lien. The network helps show where Tzu‐Wen Lien may publish in the future.

Co-authorship network of co-authors of Tzu‐Wen Lien

This figure shows the co-authorship network connecting the top 25 collaborators of Tzu‐Wen Lien. A scholar is included among the top collaborators of Tzu‐Wen Lien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tzu‐Wen Lien. Tzu‐Wen Lien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Mu‐Chun, Mohane Selvaraj Coumar, Shu‐Yu Lin, et al.. (2023). Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 66(4). 2566–2588. 10 indexed citations
2.
Lin, Shu‐Yu, Yi-Yu Ke, Wen‐Hsing Lin, et al.. (2019). Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 62(22). 10108–10123. 30 indexed citations
3.
Lin, Wen‐Hsing, Jen‐Shin Song, Tzu‐Wen Lien, et al.. (2012). A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors.. PubMed. 32(1). 147–51. 3 indexed citations
4.
Cheung, Chun Hei Antonio, Wen‐Hsing Lin, John Tsu‐An Hsu, et al.. (2011). BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells. PLoS ONE. 6(8). e23485–e23485. 15 indexed citations
5.
Lin, Wen‐Hsing, et al.. (2011). Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells. Biochemical Pharmacology. 81(11). 1263–1270. 49 indexed citations
6.
Lin, Chia‐Hui, Mohane Selvaraj Coumar, Santhosh Kumar Chittimalla, et al.. (2009). Design and Structural Analysis of Novel Pharmacophores for Potent and Selective Peroxisome Proliferator-activated Receptor γ Agonists. Journal of Medicinal Chemistry. 52(8). 2618–2622. 18 indexed citations
7.
Coumar, Mohane Selvaraj, Paritosh Shukla, Jian-Sung Wu, et al.. (2009). Structure-Based Drug Design of Novel Aurora Kinase A Inhibitors: Structural Basis for Potency and Specificity. Journal of Medicinal Chemistry. 52(4). 1050–1062. 64 indexed citations
8.
Lin, Wen‐Hsing, Jen‐Shin Song, Chunyu Chang, et al.. (2008). A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors. Analytical Biochemistry. 377(1). 89–94. 8 indexed citations
9.
Chou, Yu‐Cheng, Ekambaranellore Prakash, Tzu‐Wen Lien, et al.. (2008). Bioassay‐guided purification and identification of PPARα/γ agonists from Chlorella sorokiniana. Phytotherapy Research. 22(5). 605–613. 30 indexed citations
10.
Mahindroo, Neeraj, Chun-Chen Liao, Chien-Fu Huang, et al.. (2006). Indol-1-yl Acetic Acids as Peroxisome Proliferator-Activated Receptor Agonists:  Design, Synthesis, Structural Biology, and Molecular Docking Studies. Journal of Medicinal Chemistry. 49(3). 1212–1216. 64 indexed citations
11.
Mahindroo, Neeraj, Yi‐Hui Peng, Chia‐Hui Lin, et al.. (2006). Structural Basis for the Structure−Activity Relationships of Peroxisome Proliferator-Activated Receptor Agonists. Journal of Medicinal Chemistry. 49(21). 6421–6424. 25 indexed citations
12.
Lu, I-Lin, Chien-Fu Huang, Yi‐Hui Peng, et al.. (2006). Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists:  Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities. Journal of Medicinal Chemistry. 49(9). 2703–2712. 86 indexed citations
13.
Lee, Jin‐Ching, et al.. (2005). High-Throughput Cell-Based Screening for Hepatitis C Virus NS3/4A Protease Inhibitors. Assay and Drug Development Technologies. 3(4). 385–392. 12 indexed citations
14.
Wu, Yu-Shan, Chun-Wei Chang, Tzu‐Wen Lien, et al.. (2005). Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system. Bioorganic & Medicinal Chemistry. 14(1). 83–91. 97 indexed citations
15.
Lin, Tiao‐Yin, et al.. (2005). Inhibition of Hepatitis C Virus Replication by Antimonial Compounds. Antimicrobial Agents and Chemotherapy. 49(10). 4197–4202. 6 indexed citations
16.
Song, Yen-Ling, et al.. (2003). Haemolymph parameters of Pacific white shrimp (Litopenaeus vannamei) infected with Taura syndrome virus. Fish & Shellfish Immunology. 14(4). 317–331. 122 indexed citations
17.
Lien, Tzu‐Wen, et al.. (2002). Genomic Similarity of Taura Syndrome Virus (TSV) between Taiwan and Western Hemisphere Isolates.. Fish Pathology. 37(2). 71–75. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce Wisely Breakdown of academic impact, for papers by Alex Philchenkov Breakdown of academic impact, for papers by Xia‐Juan Huan Breakdown of academic impact, for papers by Yongchun Shen Breakdown of academic impact, for papers by Jessica E. Friedman Breakdown of academic impact, for papers by Shingo Yogosawa Breakdown of academic impact, for papers by Ying Hou Breakdown of academic impact, for papers by Joan Villena Breakdown of academic impact, for papers by Meiyang Xi Breakdown of academic impact, for papers by Taichi Ohshiro
Rankless by CCL
2026